BACKGROUND: Underuse of effective stroke prevention measures has been demonstrated in the general population. Blacks and Hispanics are at increased risk of recurrent stroke relative to white non-Hispanics. More profound underuse of prevention measures may contribute to this disparity. In this study we attempted to compare the degree of underuse of diagnostic and treatment strategies in patients of these racial/ethnic groups with recent ischemic stroke. METHODS: At 4 participating urban hospitals, patient charts were reviewed with regard to the completeness of the diagnostic evaluation, discharge treatment regimen, and stroke risk factor and antithrombotic medication use at 6 months postdischarge. RESULTS: Of 501 patients hospitalized with acute ischemic stroke, almost all received electrocardiograms and brain imaging, 75% had carotid artery evaluations, and 70% had serum lipid determinations. Blacks and women were less likely to have complete evaluations. At discharge, 88% of patients received antithrombotic medications and 89% of patients were prescribed antihypertensive medications appropriately, but only 65% were prescribed lipid-lowering medications appropriately, with blacks least likely to receive appropriate prescriptions. At 6 months poststroke, of the 200 patients with data available for evaluation, 72% exhibited underuse of at least one stroke prevention measure. Blacks (81.6%) were more likely to experience underuse than Hispanics (62.5%) or whites (66.7%). Women were more likely to receive incomplete inhospital evaluations and discharge regimens. CONCLUSIONS: There is clinically important underuse of effective diagnostic and prevention measures in each of the groups studied, especially among blacks.
BACKGROUND: Underuse of effective stroke prevention measures has been demonstrated in the general population. Blacks and Hispanics are at increased risk of recurrent stroke relative to white non-Hispanics. More profound underuse of prevention measures may contribute to this disparity. In this study we attempted to compare the degree of underuse of diagnostic and treatment strategies in patients of these racial/ethnic groups with recent ischemic stroke. METHODS: At 4 participating urban hospitals, patient charts were reviewed with regard to the completeness of the diagnostic evaluation, discharge treatment regimen, and stroke risk factor and antithrombotic medication use at 6 months postdischarge. RESULTS: Of 501 patients hospitalized with acute ischemic stroke, almost all received electrocardiograms and brain imaging, 75% had carotid artery evaluations, and 70% had serum lipid determinations. Blacks and women were less likely to have complete evaluations. At discharge, 88% of patients received antithrombotic medications and 89% of patients were prescribed antihypertensive medications appropriately, but only 65% were prescribed lipid-lowering medications appropriately, with blacks least likely to receive appropriate prescriptions. At 6 months poststroke, of the 200 patients with data available for evaluation, 72% exhibited underuse of at least one stroke prevention measure. Blacks (81.6%) were more likely to experience underuse than Hispanics (62.5%) or whites (66.7%). Women were more likely to receive incomplete inhospital evaluations and discharge regimens. CONCLUSIONS: There is clinically important underuse of effective diagnostic and prevention measures in each of the groups studied, especially among blacks.
Authors: Eric M Cheng; Salomeh Keyhani; Susan Ofner; Linda S Williams; Paul L Hebert; Diana L Ordin; Dawn M Bravata Journal: Neurology Date: 2012-06-13 Impact factor: 9.910
Authors: Karen C Albright; Lei Huang; Justin Blackburn; George Howard; Michael Mullen; Vera Bittner; Paul Muntner; Virginia Howard Journal: Neurology Date: 2018-10-03 Impact factor: 9.910
Authors: Kimberly D Martin; Lisa Naert; Larry B Goldstein; Stanislav Kasl; Annette M Molinaro; Judith H Lichtman Journal: J Stroke Cerebrovasc Dis Date: 2011-03-16 Impact factor: 2.136
Authors: Judith Z Goldfinger; Ian M Kronish; Kezhen Fei; Albert Graciani; Peri Rosenfeld; Kate Lorig; Carol R Horowitz Journal: Contemp Clin Trials Date: 2012-06-15 Impact factor: 2.226
Authors: Marjan Mujib; Grigorios Giamouzis; Syed Abbas Agha; Inmaculada Aban; Nalini Sathiakumar; O James Ekundayo; Edward Zamrini; Richard M Allman; Javed Butler; Ali Ahmed Journal: Int J Cardiol Date: 2009-05-12 Impact factor: 4.164
Authors: Ian M Kronish; Judith Z Goldfinger; Rennie Negron; Kezhen Fei; Stanley Tuhrim; Guedy Arniella; Carol R Horowitz Journal: Stroke Date: 2014-09-23 Impact factor: 7.914